Waljit Dhillo, Professor in Endocrinology & Metabolism, Consultant Endocrinologist and an NIHR Research Professor at Imperial College London has joined KaNDy Therapeutics as a Scientific and Clinical Advisor.

Professor Dhillo will be working with the KaNDy team to support the development of NT-814 as a breakthrough treatment for multiple symptoms of the menopause. He will also be active in helping to progress additional indications for this unique dual mechanism neurokinin-1,3 receptor antagonist. Professor Dhillo is working with KaNDy therapeutics, independently, through Imperial Consultants